Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir

Abstract

In patients with moderate-to-severe lipodystrophy, significant improvements in subcutaneous fat continued over 104 weeks after switching from a thymidine analogue to ABC. Nevertheless, the lipodystrophy syndrome was still evident, indicating additional strategies need evaluating.